XML 29 R12.htm IDEA: XBRL DOCUMENT v3.24.1
Research and Development Costs
12 Months Ended
Dec. 31, 2023
Research and Development [Abstract]  
Research and Development Costs

3. Research and Development Costs

 

A summary of research and development costs for the years ended December 31, 2023 and 2022, including costs associated with clinical trials involving the Company’s lead clinical compound LB-100, are summarized below based on the respective geographical regions where such costs have been incurred.

  

   2023   2022 
  

Years Ended December 31,

 
   2023   2022 
         
United States  $359,589   $350,618 
Spain   295,163    626,366 
France       91,532 
China   17,198    76,595 
Netherlands   226,150    204,158 
Total  $898,100   $1,349,269